Lanthanum Carbonate Patent Expiration
Lanthanum Carbonate is Used for lowering serum phosphate levels in patients with end stage renal disease. It was first introduced by Takeda Pharmaceuticals Usa Inc
Lanthanum Carbonate Patents
Given below is the list of patents protecting Lanthanum Carbonate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fosrenol | US8980327 | Capsule and powder formulations containing lanthanum compounds | Dec 01, 2030 | Takeda Pharms Usa |
| Fosrenol | US9023397 | Capsule and powder formulations containing lanthanum compounds | Dec 01, 2030 | Takeda Pharms Usa |
| Fosrenol | US7381428 | Stabilized lanthanum carbonate compositions |
Aug 26, 2024
(Expired) | Takeda Pharms Usa |
| Fosrenol | US7465465 | Pharmaceutical formulation comprising lanthanum compounds |
Aug 26, 2024
(Expired) | Takeda Pharms Usa |
| Fosrenol | US5968976 | Pharmaceutical composition containing selected lanthanum carbonate hydrates |
Oct 26, 2018
(Expired) | Takeda Pharms Usa |
Lanthanum Carbonate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List